Material matter: in-licensing deal for Opakalim and other epilepsy drug candidates
DART
SK biopharmaceuticals Co., Ltd.
Filed Aug 26, 2026 KST · Filing
· receipt 20260826800139
kstock has not written this one up.
The title above is a translation of the Korean form name; the filing itself is on DART, in
Korean.
Read the original on DART ↗Korean. DART is Korea's electronic disclosure system, run by the Financial Supervisory
Service — the filing equivalent of EDGAR.
Korean form name: 투자판단관련주요경영사항 (뇌전증 신약 후보 물질 Opakalim 등에 대한 라이선스 인 계약)